FIELD: experimental cardiopharmacology.
SUBSTANCE: in an experiment, endothelial dysfunction is simulated by daily, over a 7-day period, intraperitoneal introduction of L-arginine methyl ether to rats in dose of 25 mg/kg. Then, on the 7th day since the beginning of experiment, lozartan in dose 6 mg/kg is introduced intragastrically and razveratrol in dose 2 mg/kg intraperitoneally once a day.
EFFECT: increased correction efficiency under specific experiment conditions.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF LOSARTAN AND L-ARGININE IN L-NAME-INDUCED NITROGEN DEFICIT | 2005 |
|
RU2306930C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH SOLVENT MIXTURE OF HOMEOPATHIC DILUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE C12, C30, C200 | 2006 |
|
RU2306953C1 |
| METHOD FOR CORRECTING ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF INDAPAMIDE AND RESVERATROL AT L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2302241C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY COMBINATION OF ENALAPRIL AND RESVERATROL IN L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 |
|
RU2301670C1 |
| METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION BY PHOSPHOGLIV PREPARATION AT L-NAME INDUCED DEFICIENCY OF NITROGEN OXIDE | 2008 |
|
RU2359668C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH PREPARATION PHOSPHOGLIV LYOPHILIZATE IN L-NAME INDUCED NITROGEN OXIDE DEFICIENCY | 2008 |
|
RU2372078C1 |
| METHOD FOR CORRECTING ENDOTHELIAL DYSFUNCTION | 2005 |
|
RU2271202C1 |
| METHOD OF CORRECTION OF ENDOTHELIAL DYSFUNCTION USING LOZARTAN IN COMPLEX WITH ADMIXTURE OF SOLUTIONS OF HOMEOPATHIC DELUTIONS OF POLYCLONAL RABBIT ANTIBODIES TO ENDOTHELIAL SYNTHASE OF HUMAN NITROGEN OXIDE-C12, C30, C200 | 2007 |
|
RU2343927C1 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF INDAPAMIDE AND L-ARGININE IN L-NAME-INDUCED NITROGEN DEFICIT | 2005 |
|
RU2306929C1 |
